Agilent is a global leader in life sciences, diagnostics, and applied chemical markets, providing instruments, software, services, and consumables to laboratories worldwide. The company contributes to meeting customer needs in research, clinical, and industrial applications through innovative measurement solutions. Established in 1999 as a spin-off from Hewlett-Packard, it maintains technological leadership in analytical instrumentation. Approximately 18,000 employees support customers in over 110 countries, demonstrating a broad global presence.Agilentisagloballeaderinlifesciences,diagnostics,andappliedchemicalmarkets,providinginstruments,software,services,andconsumablestolaboratoriesworldwide.Thecompanycontributestomeetingcustomerneedsinresearch,clinical,andindustrialapplicationsthroughinnovativemeasurementsolutions.Establishedin1999asaspin-offfromHewlett-Packard,itmaintainstechnologicalleadershipinanalyticalinstrumentation.Approximately18,000employeessupportcustomersinover110countries,demonstratingabroadglobalpresence.
Key Products/TechnologiesKeyProducts/Technologies
Chromatography: Gas Chromatography (GC) systems (e.g., 8850 GC, 7890A Gas Chromatographs), Liquid Chromatography (LC) and Ultra-High Performance Liquid Chromatography (UHPLC) systems (e.g., InfinityLab LC Series, 1290 Infinity III LC), along with related columns (e.g., Agilent J&W GC HP-5, Poroshell) and consumables.Chromatography:GasChromatography(GC)systems(e.g.,8850GC,7890AGasChromatographs),LiquidChromatography(LC)andUltra-HighPerformanceLiquidChromatography(UHPLC)systems(e.g.,InfinityLabLCSeries,1290InfinityIIILC),alongwithrelatedcolumns(e.g.,AgilentJ&WGCHP-5,Poroshell)andconsumables.
Mass Spectrometry: Liquid Chromatography/Mass Spectrometry (LC/MS) systems (e.g., InfinityLab Pro iQ Series, 6495D LC/TQ, Revident LC/Q-TOF), Gas Chromatography/Mass Spectrometry (GC/MS) systems (e.g., 7000B Triple Quadrupole GC–MS), and Inductively Coupled Plasma Mass Spectrometry (ICP-MS) systems (e.g., 7500 Series ICP–MS) among various mass spectrometry instruments.MassSpectrometry:LiquidChromatography/MassSpectrometry(LC/MS)systems(e.g.,InfinityLabProiQSeries,6495DLC/TQ,RevidentLC/Q-TOF),GasChromatography/MassSpectrometry(GC/MS)systems(e.g.,7000BTripleQuadrupoleGC–MS),andInductivelyCoupledPlasmaMassSpectrometry(ICP-MS)systems(e.g.,7500SeriesICP–MS)amongvariousmassspectrometryinstruments.
Technological Leadership and Innovation Capability: Possession of technological leadership in analytical instrumentation and continuous innovation capability through R&D investment.TechnologicalLeadershipandInnovationCapability:PossessionoftechnologicalleadershipinanalyticalinstrumentationandcontinuousinnovationcapabilitythroughR&Dinvestment.
Integrated Workflow Solutions Provision: Ability to provide integrated workflow solutions encompassing instruments, software, consumables, and services.IntegratedWorkflowSolutionsProvision:Abilitytoprovideintegratedworkflowsolutionsencompassinginstruments,software,consumables,andservices.
Strong Brand Equity and Customer Loyalty: Strong brand recognition and customer trust based on a long history and heritage in measurement science.StrongBrandEquityandCustomerLoyalty:Strongbrandrecognitionandcustomertrustbasedonalonghistoryandheritageinmeasurementscience.
Global Presence and Service Network: An extensive global R&D, manufacturing, sales, and support network assisting customers in over 110 countries.GlobalPresenceandServiceNetwork:AnextensiveglobalR&D,manufacturing,sales,andsupportnetworkassistingcustomersinover110countries.
Diversified Portfolio and Market Leadership: Market leadership in gas chromatography, a top-three position in LC and MS, and expansion into diagnostics and biopharmaceutical sectors.DiversifiedPortfolioandMarketLeadership:Marketleadershipingaschromatography,atop-threepositioninLCandMS,andexpansionintodiagnosticsandbiopharmaceuticalsectors.
Sustainable Revenue Model: A recurring revenue structure exceeding 50% from consumables and services, built upon a large installed base from high-end instrument sales.SustainableRevenueModel:Arecurringrevenuestructureexceeding50%fromconsumablesandservices,builtuponalargeinstalledbasefromhigh-endinstrumentsales.
Patent Holdings: A global portfolio of 15,961 patents, with 5,982 granted patents.PatentHoldings:Aglobalportfolioof15,961patents,with5,982grantedpatents.
Active Patents: Over 21% of the 15,961 patents are active.ActivePatents:Over21%ofthe15,961patentsareactive.
Primary Patent Filing Regions: The United States as the leading region for patent filings, followed by Europe and Japan.PrimaryPatentFilingRegions:TheUnitedStatesastheleadingregionforpatentfilings,followedbyEuropeandJapan.
Chromatography/Spectroscopy Related Patents: Patents for various products and components including Quiet Cover (7530366), Capillary Flow Technology (7507336), Poroshell (10618920), and Zorbax (7588683).Chromatography/SpectroscopyRelatedPatents:PatentsforvariousproductsandcomponentsincludingQuietCover(7530366),CapillaryFlowTechnology(7507336),Poroshell(10618920),andZorbax(7588683).
CRISPR Technology Patents: Joint ownership with Stanford University for CRISPR/Cas-based gene regulation patents (11306309).CRISPRTechnologyPatents:JointownershipwithStanfordUniversityforCRISPR/Cas-basedgeneregulationpatents(11306309).
Technological Competitiveness: Approximately 4,000 active patents in ion source technology and microfluidics, ensuring superior sensitivity and uptime for MS and LC systems, thereby differentiating products.TechnologicalCompetitiveness:Approximately4,000activepatentsinionsourcetechnologyandmicrofluidics,ensuringsuperiorsensitivityanduptimeforMSandLCsystems,therebydifferentiatingproducts.
Certifications: The InfinityLab LC Series Portfolio holds My Green Lab Certified with Ecolabel 2.0 certification.Certifications:TheInfinityLabLCSeriesPortfolioholdsMyGreenLabCertifiedwithEcolabel2.0certification.
Introduction
Location
5301 Stevens Creek Blvd, Santa Clara, CA 95051, USA
클릭하여 위치 살펴보기
Information
5301 Stevens Creek Blvd, Santa Clara, CA 95051, USA